Table 2.
Variable | 5‐year overall survival rate | P‐value |
---|---|---|
Age at RT, years | 0.321 | |
<70 | 14% | |
≥70 | 42% | |
Patient sex | 0.214 | |
Female | 29% | |
Male | 22% | |
Histology | 0.031 | |
SCC | 43% | |
Other | 8% | |
Stage | 0.023 | |
I/II | 50% | |
III | 17% | |
Chemotherapy | 0.077 | |
No | 40% | |
Yes | 19% | |
RT type | 0.982 | |
Proton | 29% | |
Photon | 20% | |
IgG response | 0.799 | |
Absent | 32% | |
Present | 14% | |
IgM response | 0.194 | |
Absent | 38% | |
Present | 15% | |
IgG or IgM response | 0.303 | |
Absent | 40% | |
Present | 19% |
RT, radiation therapy; SCC, squamous cell carcinoma.